8-Benzyloxy-5-(2-Bromoacetyl)-2-Hydroxyquinoline CAS 100331-89-3
Supple Commercial Indacaterol Maleate (CAS: 753498-25-8) Intermedia:
5,6-Diethyl-2,3-dihydro-1H-inden-2-amine hydrochloridi CAS: 312753-53-0
8-Benzyloxy-5-(2-Bromoacetyl)-2-Hydroxyquinoline CAS: 100331-89-3
5-(2R)-2-Oxiranyl-8-benzyloxy-2(1H)-quinolinone CAS: 173140-90-4
Nomen chemicum | 8-Benzyloxy-5-(2-Bromoacetyl)-2-Hydroxyquinoline |
Synonyma | 8-(Benzyloxy)-5-(2-Bromoacetyl)quinolin-2(1H)-one;5-(Bromoacetyl)-8-(Phenylmethoxy)-2(1H)-Quinolinone;5-(2-Bromo-1-Oxoethyl)-8-Benzyloxy-2(1H)-Quinolinone;5-Bromoacetyl-8-Benzyloxycarbostyril |
CAS Number | 100331-89-3 |
Stock Status | In Stock, Productio Ascendite usque ad Centum chiliogrammata |
Formulae hypotheticae | C18H14BrNO3 |
M. Pondus | 372.21 |
Liquescens punctum | 192.0~ 194.0℃ |
Ferveret | 602.6±55.0℃ at 760 mmHg |
Density | 1.479±0.06 g/cm3 |
Brand | Ruifu Chemical |
Item | Specifications |
Aspectus | Off-White ad Yellow pulveris |
Puritas / Analysis Methodus | >95.0% (HPLC) |
Humor (KF) | <1.00% |
Requiesce in ignitio | <0.50% |
immunditiam A | <3.00% (5-Acetyl-8-(Benzyloxy)quinolin-2(1H)-one) |
Alia alia immunditia | <1.50% |
Totalis immunditias | <5.00% |
Infrared Imaginis | Conformat ut Structure |
Test Standard | Enterprise Standard |
Consuetudinem | Indacaterol Maleate (CAS: 753498-25-8) Intermedia |
Sarcina:Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris.
Repono Condition:Continentem arcte clausam et in frigido, sicco et bene ventilato horreis a substantiis incompossibilibus repone.A luce et humore protege.
Naviportans:Libera ad mundum ab aere, per FedEx / DHL Express.Ieiunium et certas traditiones provide.
Shanghai Ruifu Chemical Co., Ltd. est primarius fabrica et supplementum 8-Benzyloxy-5-(2-Bromoacetyl) -2-Hydroxyquinolicum (CAS: 100331-89-3) cum qualitate magna, est medium typice in synthesis Indacaterol Maleate (CAS: 753498-25-8).
Indacaterol Maleate (CAS: 753498-25-8) novum est, ultra-longum agens, β(2)-adrenoceptor agonista et bronchodilator.Usus est in curatione longi morborum pulmonis obstructivorum (COPD) et asthmatis.Medicinae Europaeae Agency (EMA) indacaterolum medicamentum in MMIX sub nomine artis Onbrez approbavit, dum in Civitatibus Foederatis Administratione Cibus et Medicamento approbavit sub commercio nomine Arcapta anno 2011. Medicamentum fictum est ut eius forma sal maleata.Item, indacaterol est moleculum chirurgicum;pura vero tantum R-enantiomer distribuitur.